Anti-EPCR/CD201 antibody [EPR25647-5]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Anti-EPCR/CD201 antibody [EPR25647-5] is a Rabbit Monoclonal antibody that is used in EPCR/CD201 Flow Cytometry, ICC/IF, IP, Western Blot. Suitable for Human samples.
Endothelial Protein C Receptor (EPCR), also known as CD201, plays a significant role in tumor progression by enhancing cell survival, proliferation, and migration. EPCR binds to APC, which then activates PAR-1. This activation leads to anti-inflammatory and cytoprotective effects that can create a favorable environment for tumor cells to thrive. EPCR is overexpressed in several cancers including epithelial cancer and is a ligand for gamma-delta T cells. EPCR promotes breast cancer invasion and 3D growth.
View Alternative Names
CD201, EPCR, PROCR, Endothelial protein C receptor, Activated protein C receptor, Endothelial cell protein C receptor, APC receptor
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-EPCR/CD201 antibody [EPR25647-5] (AB300525)
Flow cytometric analysis of Jurkat (human T cell leukemia T lymphocyte, Left) / HUVEC (human umbilical vein endothelial cell, Right) cells labelling EPCR/CD201 with ab300525 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.Negative control : Jurkat (PMID : 11703343).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-EPCR/CD201 antibody [EPR25647-5] (AB300525)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HUVEC (human umbilical vein endothelial cell) cells labelling EPCR/CD201 with ab300525 at 1/50 (9.8 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing cytoplasmic and membranous staining in HUVEC cell lineNegative control : Jurkat (PMID : 11703343) is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5 ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-EPCR/CD201 antibody [EPR25647-5] (AB300525)
EPCR/CD201 was immunoprecipitated from 0.35 mg HUVEC (human umbilical vein endothelial cell) whole cell lysate 10 ug with ab300525 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab300525 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP)(ab131366) was used at 1/1000 dilution. Lane 1 : HUVEC (human umbilical vein endothelial cell) whole cell lysate 10 ug Lane 2 : ab300525 IP in HUVEC whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab300525 in HUVEC whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 3 minutes
Lane 1:
Immunoprecipitation - Anti-EPCR/CD201 antibody [EPR25647-5] (ab300525) at 1/30 dilution
Lane 2:
Immunoprecipitation - Anti-EPCR/CD201 antibody [EPR25647-5] (ab300525) at 1/1000 dilution
All lanes:
HUVEC whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-EPCR/CD201 antibody [EPR25647-5] (AB300525)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Negative control : Jurkat (PMID : 7929370)
Exposure time : Lanes 1-4 : 103 seconds; Lanes 5-6 : 3 minutes
All lanes:
Western blot - Anti-EPCR/CD201 antibody [EPR25647-5] (ab300525) at 1/1000 dilution
Lane 1:
HUVEC (human umbilical vein endothelial cell), whole cell lysate at 10 µg
Lane 2:
Ea.Hy926 (human somatic cell hybrid endothelial), whole cell lysate at 10 µg
Lane 3:
RKO (human colon epithelial cell), whole cell lysate at 10 µg
Lane 4:
Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 10 µg
Lane 5:
Human placenta tissue lysate at 10 µg
Lane 6:
Human lung tissue lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 27 kDa
Observed band size: 45 kDa
false
- WB
Lab
Western blot - Anti-EPCR/CD201 antibody [EPR25647-5] (AB300525)
Exposure time : ab300525 : 180 seconds; ab300565 : 5 seconds
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
The band beneath the target band is supposed to be a soluble form (PMID : 19806250).
ab300525 is less sensitive than ab300565. ab300525 needs a high sensitivity ECL substrate.
Lanes 1-5 & 11-15 use a normal normal ECL substrate.
Lanes 6-10 use a High sensitivity ECL substrate.
Lanes 1 - 15:
Western blot - Anti-EPCR/CD201 antibody [EPR25647-5] (ab300525) at 1/1000 dilution
Lanes 11 - 15:
Western blot - Anti-EPCR/CD201 antibody [EPR25647-49] (<a href='/en-us/products/primary-antibodies/epcr-cd201-antibody-epr25647-49-ab300565'>ab300565</a>) at 1/1000 dilution
Lanes 1, 6 and 11:
Human lung tissue lysate at 20 µg
Lanes 2, 7 and 12:
HUVEC (Human umbilical vein endothelial cell) whole cell lysate at 20 µg
Lanes 3, 8 and 13:
Ea.Hy926 ( human somatic cell hybrid endothelial) whole cell lysate at 20 µg
Lanes 4, 9 and 14:
RKO (human colorectal carcinoma cell) whole cell lysate at 20 µg
Lanes 5, 10 and 15:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 45 kDa
false
- WB
Supplier Data
Western blot - Anti-EPCR/CD201 antibody [EPR25647-5] (AB300525)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Western blot - Anti-EPCR/CD201 antibody [EPR25647-5] (ab300525) at 1/1000 dilution
Lane 1:
Untreated HUVEC whole cell lysate at 10 µg
Lane 2:
HUVEC whole cell lysate treated with Protein Deglycosylation Mix II at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 27 kDa
Observed band size: 45 kDa
true
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-EPCR/CD201 antibody [EPR25647-5] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The EPCR is part of the protein C anticoagulant pathway where it acts as a cofactor. EPCR is vital in enhancing the activation of protein C on the endothelial surface reducing coagulation activity. It interacts closely with thrombomodulin and protein C to form this complex preventing excessive thrombus formation and contributing to vascular integrity. Apart from its anticoagulant role EPCR also modulates inflammatory responses supporting its function as a bridge between coagulation and inflammation.
Pathways
EPCR lies within the protein C anticoagulation pathway and the endothelial signaling pathways. Its primary partner in the anticoagulation pathway is APC which degrades activated factors Va and VIIIa providing a check against coagulation. Additionally EPCR’s interaction with APC and thrombomodulin links this protein to the endothelial signaling pathway where it affects cell survival and inflammation regulation. This interaction is essential to maintain hemostatic balance and control vascular responses to inflammatory stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com